These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3825645)

  • 1. [Prognostic value of serum prolactin in the treatment of prostatic cancer].
    Maganto E; Jiménez M; Burgos J; Escribano G; Allona A; Escudero A
    Actas Urol Esp; 1986; 10(6):441-4. PubMed ID: 3825645
    [No Abstract]   [Full Text] [Related]  

  • 2. [The prognostic significance of prolactin in prostate cancer].
    Røhl HF; Andersen OP
    Ugeskr Laeger; 1987 Dec; 149(50):3402-3. PubMed ID: 3433541
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prolactin and prostate cancer. II. Blood levels of prolactin in prostatic tumors].
    Maganto Pavón E; Mayayo Dehesa T; Mateos Torres JA; Verdú Tartajo F; de Blas Gómez V; Romero Aguirre C
    Arch Esp Urol; 1982; 35(3):171-8. PubMed ID: 6181745
    [No Abstract]   [Full Text] [Related]  

  • 4. [Increased secretion of prolactin after inhibition of dopaminergic receptors by metoclopramide in patients with cancer of the prostate].
    Baranowska B; Jeske W; Szymanowski J; Piechna K
    J Urol (Paris); 1983; 89(8):601-5. PubMed ID: 6203986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prolactin and cancer of the prostate (III). Changes in plasma prolactin and testosterone after hormone treatment in prostatic cancer].
    Maganto Pavón E; Mateos Torres JA; Mayayo Dehesa T; Allona Almagro A; Boronat Tormo F; Escudero Barrilero A
    Arch Esp Urol; 1982; 35(4):222-33. PubMed ID: 7138091
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prolactin and prostatic cancer. Modification of testosterone serum levels in estrogen-induced hyperprolactinemia by bromocriptine].
    Maganto E; Mayayo T; Mateos JA; Verdú F; Escudero Barrilero A
    Actas Urol Esp; 1983; 7(4):289-94. PubMed ID: 6624577
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum prolactin assays have no prognostic value in treatment of prostatic cancer by orchidectomy or estrogens.
    Stege R; Carlström K; Eriksson A; Gustafsson SA; Henriksson P; Pousette A
    Urol Int; 1987; 42(2):124-6. PubMed ID: 3617239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone levels in benign prostatic hypertrophy and prostate cancer.
    Mearini L; Costantini E; Zucchi A; Mearini E; Bini V; Cottini E; Porena M
    Urol Int; 2008; 80(2):134-40. PubMed ID: 18362481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum interleukin 6 as a prognostic factor in patients with prostate cancer.
    Nakashima J; Tachibana M; Horiguchi Y; Oya M; Ohigashi T; Asakura H; Murai M
    Clin Cancer Res; 2000 Jul; 6(7):2702-6. PubMed ID: 10914713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum prolactin levels during therapy of prostatic cancer with oestradiol-17 beta-undecylate and cyproterone acetate (author's transl)].
    Spona J; Lunglmayr G
    Wien Klin Wochenschr; 1980 Jul; 92(14):494-7. PubMed ID: 6933738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocrine profiles in men with localized and locally advanced prostate cancer treated with radical prostatectomy.
    Heracek J; Urban M; Sachova J; Kuncova J; Eis V; Mandys V; Hampl R; Starka L
    Neuro Endocrinol Lett; 2007 Feb; 28(1):45-51. PubMed ID: 17277727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in patients with metastatic (stage D2) prostate cancer: experience from the Scandinavian Prostatic Cancer Group Study-2.
    Jørgensen T; Kanagasingam Y; Kaalhus O; Tveter KJ; Bryne M; Skjørten F; Berner A; Danielsen HE
    J Urol; 1997 Jul; 158(1):164-70. PubMed ID: 9186346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High serum prolactin associated with poor prognosis in carcinoma of the prostate.
    Mee AD; Khan O; Mashiter K
    Br J Urol; 1984 Dec; 56(6):698-701. PubMed ID: 6534494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interdependence between hormonal disorders, staging and degree of malignancy of prostatic gland cancer. 2].
    Szymanowski J; Baranowska B; Rozbicka G; Jeske W; Zgliczynski S
    J Urol (Paris); 1983; 89(9):663-8. PubMed ID: 6425418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of determining prostate specific antigen in follow-up of prostatic cancer].
    Sadeh AD; Mukamel E; Galili Y; Nussbaum B; Regev D; Servadio C
    Harefuah; 1993 Aug; 125(3-4):69-74, 128. PubMed ID: 7693556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment serum level of HER2/nue as a prognostic factor in metastatic prostate cancer patients about to undergo endocrine therapy.
    Okegawa T; Kinjo M; Nutahara K; Higashihara E
    Int J Urol; 2006 Sep; 13(9):1197-201. PubMed ID: 16984552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients.
    Lissoni P; Malugani F; Casu M; Bukovec R; Egardi R; Bordin V; Fumagalli E; Mengo S; Gardani G
    Neuro Endocrinol Lett; 2002 Feb; 23(1):61-3. PubMed ID: 11880864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
    Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
    Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum testosterone as a prognostic factor in patients with advanced prostatic carcinoma.
    Iversen P; Rasmussen F; Christensen IJ
    Scand J Urol Nephrol Suppl; 1994; 157():41-7. PubMed ID: 7939452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The search for better prognostic factors for men treated for localized prostate cancer continues.
    Karakiewicz PI; Suardi N; Shariat SF
    Eur Urol; 2008 Apr; 53(4):689-90. PubMed ID: 18093722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.